about
Inflammation and metabolic dysfunction: links to cardiovascular diseasesThe myokine decorin is regulated by contraction and involved in muscle hypertrophy.Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cellsPerilipin 4 in human skeletal muscle: localization and effect of physical activity.Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.Role of lipid-derived mediators in skeletal muscle insulin resistance.Global mRNA sequencing of human skeletal muscle: Search for novel exercise-regulated myokines.Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity.Myokines in insulin resistance and type 2 diabetes.Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes.Dual specificity phosphatase 5 and 6 are oppositely regulated in human skeletal muscle by acute exercise.Chitinase-3-like protein 1 protects skeletal muscle from TNFα-induced inflammation and insulin resistance.The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferation.IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts.Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway.Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways.Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazoneThe adipokine zinc-α2-glycoprotein activates AMP kinase in human primary skeletal muscle cellsAdipokines promote lipotoxicity in human skeletal muscle cells
P50
Q26851186-B91D0B79-4026-4108-AFD3-A1F0A75F9E65Q34427935-F903BB0F-6B8C-4F0D-AE08-44CFF1ACF92CQ34700818-6F9A8736-2A2A-4C8D-AD00-D5447290A5E2Q36036424-09270A00-DC3C-4A5E-BE79-EB67C8AAE4A2Q37429204-F2ED3A93-CED1-4AA6-B08D-BA87C9A162FCQ37551374-9FF28049-E8DC-4D45-B8C5-19AC59296966Q37724747-85D43BC5-FBB5-44B8-9501-A3415BB1375EQ37845219-348EB7F1-9EF2-4A81-975C-6423579EFC4BQ38199992-996FF718-2486-48CD-BC47-9089087180CBQ40090062-DADEE9FF-C9D8-4E42-B047-4135582E0CA5Q42378109-5489F003-20B8-456C-850B-0FDA89283A61Q53067238-DE07278F-BA10-41FE-934A-430324FD2BD7Q53374376-B13B3BD3-6DF1-4798-AEFC-A5829DF5CC5DQ53525094-3BE48B7B-A153-4461-A048-82ADD9B33734Q54470093-926CE888-1DF4-42F3-93E6-15356C76E63FQ54533770-2D4BCFD3-B9E1-4051-8A59-ECE404BDDDC5Q82964222-7A43BD4C-0730-47F7-B193-5C7B887BA8EDQ83764045-5F978366-A811-48CE-8F45-8DF134F91494Q84360516-F873F777-72EE-4CAC-A7C6-C12659A885F4
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Kristin Eckardt
@en
Kristin Eckardt
@nl
type
label
Kristin Eckardt
@en
Kristin Eckardt
@nl
prefLabel
Kristin Eckardt
@en
Kristin Eckardt
@nl
P31
P496
0000-0003-3519-6261